We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI-Guided Radiation Therapy System Offers Integrated Imaging and Radiation Therapy

By MedImaging International staff writers
Posted on 05 Jun 2012
New technology features a novel combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer. The system provides continuous soft-tissue imaging during treatment so that clinicians can see and record precisely where radiation therapy is being delivered, as it is being delivered.

ViewRay, Inc. (Cleveland, OH, USA), a medical device company, has received US Food and Drug Administration (FDA) 510(k) premarket notification clearance for its MRI-guided radiation therapy system. ViewRay’s treatment planning and delivery software received 510(k) premarket notification clearance in 2011.

“FDA clearance of our integrated system is a major milestone in the development of our technology,” said ViewRay president and CEO Gregory M. Ayers, MD, PhD. “It has already been an exciting year for ViewRay, with an additional round of funding and the installation of our first research systems at major US medical centers. Early clinical imaging studies have verified the quality of the system’s MR images, and now we’re looking forward to clinical applications.”

ViewRay’s patented cancer treatment technology was invented by company founder James F. Dempsey, PhD, while he was a member of the radiation oncology faculty at the University of Florida. “ViewRay began with the idea that we need to see what exactly we’re doing when we treat cancer patients with radiation therapy,” said Dr. Dempsey, now ViewRay’s chief scientific officer. “Thanks to our clear vision, an outstanding engineering team, and dedicated leadership, we’re now able to bring that idea into the clinic, where it can help cancer patients.”

ViewRay recently closed the final tranche of a USD 45 million round of Series C venture capital financing intended to advance the ViewRay system toward commercialization. The first ViewRay system is installed at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (St. Louis, MO, USA), where early imaging studies have taken place.

Related Links:

ViewRay



New
Post-Processing Imaging System
DynaCAD Prostate
X-Ray Illuminator
X-Ray Viewbox Illuminators
3T MRI Scanner
MAGNETOM Cima.X
Portable X-ray Unit
AJEX140H

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.